EPO and cholangiocarcinoma: CCA associated endothelial cells highly express erythropoietin receptor (EpoR) that bind to liver‐cell‐released erythropoietin (Epo) in the tumour microenvironment, thus promoting proliferation, survival, and invasion of CCA cells.90